MX2016013589A - Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo. - Google Patents

Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo.

Info

Publication number
MX2016013589A
MX2016013589A MX2016013589A MX2016013589A MX2016013589A MX 2016013589 A MX2016013589 A MX 2016013589A MX 2016013589 A MX2016013589 A MX 2016013589A MX 2016013589 A MX2016013589 A MX 2016013589A MX 2016013589 A MX2016013589 A MX 2016013589A
Authority
MX
Mexico
Prior art keywords
osteopontin
inhibition
derivatives
compositions
hair growth
Prior art date
Application number
MX2016013589A
Other languages
English (en)
Inventor
Ralf Paus
Alenfall Jan
Dunér Pontus
Hultgårdh Nilsson Anna
Original Assignee
Follicum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Follicum Ab filed Critical Follicum Ab
Publication of MX2016013589A publication Critical patent/MX2016013589A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona una composición para inhibir la producción de pelo en un mamífero que comprende un componente de polipéptido activo y un excipiente, portador o diluyente farmacéuticamente aceptable y/o cosméticamente aceptable; la invención proporciona además métodos para inhibir la producción de pelo en un mamífero, por ejemplo, un ser humano.
MX2016013589A 2014-04-17 2015-04-17 Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo. MX2016013589A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1406989.2A GB201406989D0 (en) 2014-04-17 2014-04-17 Novel treatments
PCT/GB2015/051165 WO2015159099A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth

Publications (1)

Publication Number Publication Date
MX2016013589A true MX2016013589A (es) 2017-07-04

Family

ID=50928957

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013589A MX2016013589A (es) 2014-04-17 2015-04-17 Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo.

Country Status (14)

Country Link
US (1) US20170143605A1 (es)
EP (1) EP3131528A1 (es)
JP (1) JP2017513856A (es)
KR (1) KR20160136342A (es)
CN (1) CN106413734A (es)
AU (1) AU2015248652A1 (es)
BR (1) BR112016023899A2 (es)
CA (1) CA2945930A1 (es)
GB (1) GB201406989D0 (es)
IL (1) IL248084A0 (es)
MX (1) MX2016013589A (es)
RU (1) RU2016144971A (es)
SG (1) SG11201608497YA (es)
WO (1) WO2015159099A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201992562A1 (ru) * 2017-05-04 2020-07-01 Фолликум Аб Пептиды для лечения сахарного диабета
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
JP2022516400A (ja) * 2018-11-07 2022-02-28 フォリクム エービー 糖尿病治療のためのペプチド断片
EP3692978A1 (en) * 2019-02-07 2020-08-12 DSM IP Assets B.V. Novel method
WO2020161255A1 (en) * 2019-02-07 2020-08-13 Dsm Ip Assets B.V. Novel method for reducing hair growth
EP3958835B1 (en) * 2019-04-24 2023-05-24 Follicum AB Topical formulation
CA3168454A1 (en) 2020-02-25 2021-09-02 David K. Rosen Compositions and methods for stimulating hair growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
US6884772B1 (en) * 1999-10-21 2005-04-26 Kao Corporation Depilatories and agents for external use
EP1269196B1 (en) * 2000-03-23 2007-11-21 Glaxo Group Limited Method of screening for inhibitors of osteopontin
WO2008086449A2 (en) * 2007-01-09 2008-07-17 Oregon Health & Science University Synthetic osteopontin peptides and methods of use
GB2493540A (en) * 2011-08-10 2013-02-13 Follicum Ab Agents for stimulating hair growth in mammals

Also Published As

Publication number Publication date
RU2016144971A (ru) 2018-05-17
WO2015159099A1 (en) 2015-10-22
KR20160136342A (ko) 2016-11-29
AU2015248652A1 (en) 2016-10-20
CA2945930A1 (en) 2015-10-22
IL248084A0 (en) 2016-11-30
SG11201608497YA (en) 2016-11-29
RU2016144971A3 (es) 2018-11-30
BR112016023899A2 (pt) 2018-06-05
US20170143605A1 (en) 2017-05-25
GB201406989D0 (en) 2014-06-04
EP3131528A1 (en) 2017-02-22
JP2017513856A (ja) 2017-06-01
CN106413734A (zh) 2017-02-15

Similar Documents

Publication Publication Date Title
MX2016013589A (es) Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo.
MY191581A (en) Anti-pd-1 antibodies
MX2017016655A (es) Formulaciones oftalmicas de inhibidores de tirosina quinasa, metodos de uso de las mismas y metodos de preparacion de las mismas.
WO2015038796A3 (en) Secretion of heme-containing polypeptides
PH12015502041B1 (en) Heteroaryl compounds and uses thereof
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
MY190835A (en) Bicyclic heterrocyclic derivatives as bromodomain inhibitors
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
MX2018001324A (es) Forma cristalina de base libre de lorlatinib.
MX2018004664A (es) Antagonistas de ep4.
MX2015011770A (es) Inhibidores dipeptídicos y tripeptídicos de epoxi cetona proteasa.
MX2022006768A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
PH12017500451A1 (en) Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl) oxy)-n, 2-dimethylbenzofuran -3- carboxamide
MX2022006817A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
MX2018005785A (es) Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos.
MX2020012893A (es) Formulaciones de proteinas.
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
PH12016501997B1 (en) Cycloalkyl-linked diheterocycle derivatives
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
IN2013MU01985A (es)
CA3011003A1 (en) Bacterial ghosts for the treatment of cancer
MX2018007231A (es) Una composicion antimicrobiana.